Literature DB >> 10733121

Local somatothermal stimulation inhibits motility of the internal anal sphincter through nitrergic neural release of nitric oxide.

J K Jiang1, J H Chiu, J K Lin.   

Abstract

PURPOSE: A somatoanal reflex had been demonstrated in our previous work. Because nitric oxide plays an important role in mediating relaxation of the internal anal sphincter, our purpose was to examine whether and how local somatothermal stimulation inhibits the function of the internal anal sphincter by stimulating nitric oxide release via nitrergic neurons and to elucidate the possible mechanism.
METHODS: The activity of the internal anal sphincter in anesthetized rabbits was measured by use of continuously perfused, open-tip manometric methods. Local somatothermal stimulation was achieved by applying an electroheating rod 1 cm away from the skin area at the right popliteal region. The responses were further manipulated by pre-treating the rabbits with agonists or antagonists linked to nitric oxide synthesis.
RESULTS: The motility of the internal anal sphincter before and during local somatothermal stimulation was significantly different (tonic pressure (mean +/-standard error of the mean), 5.4 +/- 0.3 vs. 4.9 +/- 0.3 mmHg, P = 0.0195; phasic pressure, 3.9 +/- 0.6 vs. 2.9 +/- 0.4 mmHg, P = 0.0002; frequency distribution of the phasic contractions (peak-to-peak interval), 28.9 +/- 3.7 vs. 65.3 +/- 10.4 seconds, P = 0.0001). The response began at approximately one minute after local somatothermal stimulation when the skin temperature was 41 +/- 0.3 degrees C. No anal response was observed when local somatothermal stimulation was applied at the control area. The local somatothermal stimulation-induced internal anal sphincter relaxation was not inhibited by pretreatment with atropine, propranolol, or phentolamine (tonic pressure, 5.8 +/- 1 vs. 5.2 +/- 0.8 mmHg, P = 0.038; phasic pressure, 4.2 +/- 0.9 vs. 3.1 +/- 0.6 mmHg, P = 0.020; peak-to-peak interval, 27.2 +/- 4.3 vs. 52.9 +/- 14.5 seconds, P = 0.043) but was completely blocked by pretreatment with a nitric oxide synthesis inhibitor. The effect of the nitric oxide synthesis inhibitor could be reversed by pretreatment with L-arginine (tonic pressure, 6 +/- 0.7 vs. 5.6 +/- 0.7 mmHg, P = 0.047; phasic pressure, 4.7 +/- 0.7 vs. 3.9 +/- 0.5 mmHg, P = 0.048; peak-to-peak interval, 23.8 +/- 3 vs. 33 +/- 3.7 seconds, P = 0.048), but not by D-arginine.
CONCLUSION: Local somatothermal stimulation inhibits internal anal sphincter motility through the activation of nonadrenergic noncholinergic neural release of nitric oxide. This procedure may represent a simplified approach for the treatment of anorectal diseases with hypofunction of the L-arginine/nitric oxide pathway. [Key words: Local somatothermal stimulation; Nitric oxide; Internal anal sphincter; Motility; Moxibustion] Jiang J-K, Chiu J-H, Lin J-K. Local somatothermal stimulation inhibits motility of the internal anal sphincter through nitrergic neural release of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733121     DOI: 10.1007/bf02258306

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

1.  Decrease in rat internal anal pressure with the use of a topical ointment containing a killed E. coli culture suspension.

Authors:  Hiroko Kido; Hiroshi Yasukawa; Tsuyoshi Hirota; Akihiro Shindo; Tomohiro Naruse
Journal:  Int J Colorectal Dis       Date:  2006-04-21       Impact factor: 2.571

Review 2.  The mechanistic studies of acupuncture and moxibustion in Taiwan.

Authors:  Jaung-Geng Lin; Yi-Hung Chen
Journal:  Chin J Integr Med       Date:  2011-03       Impact factor: 1.978

3.  Oral administration of geranylgeranylacetone plus local somatothermal stimulation: a simple, effective, safe and operable preconditioning combination for conferring tolerance against ischemia-reperfusion injury in rat livers.

Authors:  Ning Fan; Guang-Shun Yang; Jun-Hua Lu; Ning Yang; Hai-Bin Zhang
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

4.  Effect of moxibustion at acupoints Ren-12 (Zhongwan), St-25 (Tianshu), and St-36 (Zuzanli) in the prevention of gastric lesions induced by indomethacin in Wistar rats.

Authors:  Anaflávia O Freire; Gisele C M Sugai; Miriam M Blanco; Angela Tabosa; Ysao Yamamura; Luiz Eugênio A M Mello
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

5.  Different central manifestations in response to electroacupuncture at analgesic and nonanalgesic acupoints in rats: a manganese-enhanced functional magnetic resonance imaging study.

Authors:  Jen-Hwey Chiu; Mao-Shu Chung; Hui-Cheng Cheng; Tzu-Cheng Yeh; Jen-Chuen Hsieh; Chung-Yen Chang; Wan-Yo Kuo; Henrich Cheng; Low-Tone Ho
Journal:  Can J Vet Res       Date:  2003-05       Impact factor: 1.310

6.  A comparative study of the effects of electroacupuncture and moxibustion in the gastrointestinal motility of the rat.

Authors:  Angela Tabosa; Ysao Yamamura; Eduardo Romão Forno; Luiz Eugênio A M Mello
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

7.  Preconditioning somatothermal stimulation on Qimen (LR14) reduces hepatic ischemia/reperfusion injury in rats.

Authors:  Cheng-Chu Hsieh; Shu-Chen Hsieh; Jen-Hwey Chiu; Ying-Ling Wu
Journal:  BMC Complement Altern Med       Date:  2014-01-13       Impact factor: 3.659

8.  Moxibustion Alleviates Injury in a Rat Focal Segmental Glomerulosclerosis Model.

Authors:  Yi Li; Yuxia Sun; Chunling Zhang; Ke Wang; Peicheng Shen; Di Huang; Wen Ma; Jin Zhang; Lin Li; Liqun He
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-28       Impact factor: 2.629

9.  How does moxibustion possibly work?

Authors:  Jen-Hwey Chiu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-27       Impact factor: 2.629

10.  Effects of Different Local Moxibustion-Like Stimuli at Zusanli (ST36) and Zhongwan (CV12) on Gastric Motility and Its Underlying Receptor Mechanism.

Authors:  Yang-Shuai Su; Juan-Juan Xin; Zhao-Kun Yang; Wei He; Hong Shi; Xiao-Yu Wang; Ling Hu; Xiang-Hong Jing; Bing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-12       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.